American Kidney Fund Kicks Off 7th Annual Kidney Action Week with Policy Focus
Event summary
- American Kidney Fund (AKF) launched its seventh annual Kidney Action Week, a free virtual conference running March 2-5, 2026.
- The event features 4 days of educational sessions with nephrologists, genetic counselors, renal dietitians, and patient advocates.
- AKF will hold a policy briefing discussing the Kidney Care Access Protection Act (H.R. 6214/S.2730) and its impact on Medicare coverage for innovative treatments.
- Event sponsors include U.S. Renal Care, Novartis, and Travere Therapeutics.
The big picture
AKF's Kidney Action Week underscores the growing emphasis on patient education and policy advocacy in the kidney disease space. With 1 in 7 American adults affected by kidney disease, the event highlights the need for early detection and innovative treatment options. The policy briefing on the Kidney Care Access Protection Act signals a push for legislative changes that could expand access to advanced therapies under Medicare.
What we're watching
- Policy Impact
- Whether the Kidney Care Access Protection Act gains traction and how it may reshape Medicare coverage for kidney disease treatments.
- Industry Collaboration
- The extent to which partnerships with Novartis and Travere Therapeutics drive innovation in kidney disease care.
- Patient Engagement
- The effectiveness of virtual conferences in fostering community and knowledge sharing among kidney disease patients and caregivers.
Related topics